Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.718
+0.138 (8.73%)
Jul 18, 2025, 5:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €158.34 million as of July 18, 2025. Its market cap has decreased by -3.64% in one year.
Market Cap
158.34M
Enterprise Value
108.56M
Revenue
20.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.72
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 158.34M, an increase of 19,889.32%. That is a compound annual growth rate of 32.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 112.61B |
| Sanofi | 101.77B |
| Sartorius Stedim Biotech | 18.77B |
| bioMérieux | 13.95B |
| Eurofins Scientific SE | 10.87B |
| Ipsen | 8.79B |
| Virbac | 2.97B |
| Clariane SE | 1.80B |